↑

International Patients: +91 8743024344 · Indian Patients: +91 7838223336 · Patient Reviews · Leave a Google Review ★

Type 1 Diabetes · Stem Cell Therapy

Type 1 Diabetes Stem Cell Treatment in Delhi, India

Stem cell therapy for Type 1 Diabetes is an investigational approach being studied alongside standard medical care, with potential benefits varying depending on the type and severity of the injury.

Get Free Medical Evaluation → · Upload Medical Reports → · Latest Blog on Type 1 Diabetes →

10,000+ patients treated worldwide
Stem Cell Care India doctor reviewing before-and-after brain scans on a tablet with a patient and family member during a type 1 diabetes stem cell therapy consultation
10,000+ Patients treated
65+ Countries served
Certified Accredited hospitals & labs
16+ Years GMP-certified cell processing

Quick Answer

Research into stem cell therapy for Type 1 diabetes is ongoing, particularly around its potential to regenerate beta cells and influence the autoimmune process that destroys the islets of Langerhans. Some studies have looked at improvements toward insulin independence, though the evidence remains moderate overall and outcomes depend heavily on disease stage, age of onset, and how much beta-cell function a patient still has.

Key Takeaways

On this page — 6 categories, 27 topics

01

What Stem Cell Therapy for Type 1 Diabetes Is

Type 1 diabetes is a lifelong autoimmune condition in which the body’s immune system mistakenly attacks and destroys the insulin-producing beta cells of the pancreas. Without these cells, the body cannot produce insulin on its own, so patients require insulin therapy to manage blood sugar. While stem cell therapy cannot cure Type 1 diabetes, patients who pursue treatment at Stem Cell Care India may see a meaningful reduction in symptoms and complications, along with a possible slowing of disease progression.

Patients undergoing this therapy have reported changes such as better blood sugar regulation, less frequent urination, increased stamina, and improved wound healing.

Do you know about Type 1 Diabetes?

Diabetes is often broadly associated with blood sugar and insulin, but it actually comes in two distinct forms. Type 2 diabetes, the more common form, develops when the body doesn’t produce enough insulin and also becomes resistant to the insulin it does make, leading to elevated blood sugar (hyperglycemia).

Type 1 diabetes is different — it’s an autoimmune condition in which the immune system destroys the pancreas’s insulin-producing beta cells, leaving patients dependent on insulin since their body can no longer produce it.

Age plays a role, though not always a defining one. Most people with Type 1 diabetes are diagnosed in childhood or adolescence, which is why it’s sometimes called juvenile diabetes. However, a related but distinct form — Latent Autoimmune Diabetes in Adults (LADA), sometimes referred to as Type 1.5 — tends to progress after age 30 and develops more slowly. Because of this slower onset, insulin therapy for LADA may not be needed for months or even years after diagnosis, and there remains some debate among specialists about how it should be classified relative to classic Type 1 diabetes.

02

Symptoms of Type 1 Diabetes

Common symptoms associated with Type 1 diabetes include:

  • Blurred or diminished vision
  • Frequent urination alongside constant hunger, thirst, and fatigue
  • Rapid, unexplained weight loss
  • Tingling or pricking sensations in the skin
  • Slow-healing wounds
03

Types of Type 1 Diabetes

Insulin is the hormone responsible for helping the body convert sugar, starches, and other foods into usable energy. When the body produces too little insulin — or none at all — blood sugar builds up and can lead to serious complications. Type 1 diabetes results from damage to or loss of the pancreas’s insulin-producing beta cells, and it’s generally understood in two subtypes:

Type 1a

The immune system normally works like an internal defense system, targeting cells that could cause illness. In Type 1a diabetes, it mistakenly targets the body’s own healthy beta cells. This subtype can be identified through lab testing for specific markers, including glutamic acid decarboxylase antibodies (GADA), islet cell antibodies (ICA), and insulin autoantibodies (IAA).

Adults sometimes experience a slower-progressing version known as Latent Autoimmune Diabetes of Adults (LADA), which is frequently misdiagnosed as Type 2 diabetes because its symptoms and progression can look similar at first. Many patients treated for Type 2 diabetes for years eventually require insulin once LADA-related antibodies are confirmed through blood testing.

Type 1b

This form is far rarer and is generally associated with specific ethnic or genetic backgrounds. Unlike Type 1a, there’s no detectable immune attack on beta cells, and insulin needs can fluctuate unpredictably — some patients may go through periods where insulin isn’t needed at all.

04

Causes of Type 1 Diabetes

Type 1 diabetes develops when the insulin-producing beta cells are destroyed, leaving the body unable to properly regulate blood sugar. Several factors are associated with increased risk:

  • Age: While it can develop at any age, Type 1 diabetes most often appears during childhood, adolescence, or young adulthood.
  • Gender: Some studies suggest a slightly higher incidence in men in certain populations, though the difference is not considered significant.
  • Genetics: A family history of Type 1 diabetes raises risk, as inherited genetic factors may make the immune system more likely to target beta cells.
  • Geography: Incidence varies globally, with higher rates observed in countries farther from the equator, such as Sweden and Finland, compared to countries closer to it.

Other contributing factors that have been studied include exposure to certain viruses (such as Epstein-Barr virus, mumps, and cytomegalovirus), early introduction of cow’s milk, low vitamin D levels, nitrate-contaminated drinking water, early or delayed introduction of cereals or gluten in infancy, maternal preeclampsia, and neonatal jaundice.

Most cases — an estimated 70–90% — are driven by the immune system directly attacking beta cells. Antibodies against a protein called GAD65 typically appear first, followed by antibodies against other islet-related proteins; higher antibody levels, especially when they appear in adolescence or early adulthood, are linked to greater risk. Researchers believe the trigger likely involves a combination of genetic susceptibility and an environmental factor, such as a viral infection, though the exact mechanism isn’t fully understood.

The remaining 10–30% of cases show beta-cell destruction without clear evidence of autoimmune activity — referred to as idiopathic Type 1 diabetes — and the cause in these cases remains unclear.

05

How Type 1 Diabetes Is Diagnosed

Diagnosis typically follows the appearance of classic symptoms such as elevated blood sugar and ketones in the urine. Doctors commonly rely on a combination of the following tests:

1. Fasting Blood Glucose Level

  • Measured after an overnight fast of at least 8 hours.
  • A result of 126 mg/dL or higher on two separate tests suggests diabetes.
  • Levels between 100–125 mg/dL may indicate prediabetes and warrant further monitoring.

2. Random Blood Glucose Level

  • Can be taken at any time regardless of recent food intake.
  • A reading of 200 mg/dL or higher, especially alongside symptoms like fatigue, thirst, or frequent urination, points toward diabetes.
  • Often used for quick screening or in urgent situations.

3. HbA1c (Glycated Hemoglobin Test)

  • Reflects average blood sugar over the past two to three months.
  • A result of 6.5% or higher on two separate tests confirms diabetes.
  • 5.7%–6.4% suggests prediabetes.
  • Useful for both diagnosis and ongoing monitoring.

4. Oral Glucose Tolerance Test (OGTT)

  • Measures blood glucose before and two hours after consuming a sugary drink.
  • A 2-hour reading of 200 mg/dL or higher confirms diabetes.
  • 140–199 mg/dL suggests impaired glucose tolerance.

Doctors typically combine these results with a clinical evaluation to reach a confident diagnosis and begin appropriate treatment.

06

How Stem Cell Therapy Is Approached as a Treatment for Type 1 Diabetes

Stem Cell Therapy for Type 1 Diabetes

Stem cells are the body’s own cells and carry a natural capacity to identify and help repair damaged tissue. Full effects of treatment generally take four to six months to become apparent, during which time patients may notice gradual, ongoing improvement. The procedure itself is fast — typically completed within a few hours — with minimal risk of rejection since the patient’s own cells are often used.

How does the therapy work?

One of the biggest hurdles in traditional islet transplantation is donor availability. Stem cell-based approaches aim to sidestep that limitation, along with reducing the risks of transplant rejection associated with donor tissue.

Research suggests stem cells can help form new beta cells and can multiply substantially, allowing them to support tissue regeneration. They may also help modulate the immune system so it’s less likely to continue attacking beta cells, while new cells may respond dynamically to blood sugar changes.

Two properties make stem cells particularly relevant for Type 1 diabetes: their potential to help restore weakened beta-cell function, and their potential to reduce the immune overactivity that drives the autoimmune attack in the first place.

What to expect

Patients receive treatment under the guidance of experienced specialists at Stem Cell Care India’s advanced facility in Delhi. This autologous approach — using the patient’s own cells — is designed to work alongside, rather than replace, standard diabetes management.

VIP Treatment for Patients

  • Treatment takes place in a dedicated VIP treatment room within the clinic.
  • Patients receive round-the-clock supervision from the medical team.
  • A minimum hospital stay of 3 days is recommended.
07

How It's Being Explored for Type 1 Diabetes

Stem cells are collected from the patient, processed and concentrated in a sterile laboratory environment, and then reintroduced into the body — typically at or near the site where they’re needed most, allowing them to integrate with existing tissue and support recovery of lost function.

Research indicates these cells can, under laboratory conditions, be directed to develop into insulin-producing beta cells. They may also help create a supportive microenvironment that encourages the release of regulatory immune cells, which can help moderate the autoimmune response driving Type 1 diabetes. Stem Cell Care India’s laboratory processes are designed to support this approach with appropriate equipment and protocols.

08

What the Type 1 Diabetes Treatment Process Looks Like

Day 1

  • Pick-up from the airport to the hospital
  • Initial consultation between doctor and patient to address questions
  • Admission formalities
  • Clinical examination and lab tests as prescribed by the doctor
  • Supportive therapy

Day 2

  • Stem cell procedure
  • Supportive therapies
  • Physiotherapy

Day 3

  • Supportive therapy
  • Physiotherapy
  • Discharge formalities
  • Drop-off at the airport

Note: For admission, patients should bring valid photo identification (passport, PAN card, or driving license) along with hard copies of their medical reports.

09

Delivery Techniques Used in Stem Cell Therapy for Type 1 Diabetes

Stem cells may be implanted using several delivery methods, chosen based on the patient’s condition:

  • Intravenous administration
  • Intrathecal (lumbar puncture)
  • Intra-arterial
  • Subcutaneous
  • Intramuscular
10

Changes Type 1 Diabetes Patients Sometimes Report

Because stem cells are naturally present in the body and specialize in locating and repairing weakened tissue, this therapy is designed to work with the body’s own healing processes. Meaningful results typically take around four months to develop, and the procedure itself carries minimal risk of rejection or side effects, generally taking just a few hours to complete.

Reported benefits following therapy include:

  • Better Blood Sugar Management: Supporting insulin production may help maintain more consistent glucose levels and reduce sharp highs and lows.
  • Reduced Insulin Reliance: As natural insulin production improves, some patients find they need less daily insulin.
  • Better Energy Levels: More stable blood sugar can translate into more consistent energy throughout the day.
  • Protection of Vital Organs: Steadier glucose control may help protect kidney, heart, and eye health over the long term.
  • Improved Immune Regulation: Stem cells may help moderate immune activity, potentially reducing further attacks on insulin-producing cells.
  • Faster Healing: Improved circulation and immune balance may support quicker wound healing and fewer infections.
  • Improved Quality of Life: Better symptom management often brings greater confidence and day-to-day comfort.

While not a cure, the therapy represents a meaningful area of progress in supporting Type 1 diabetes management.

11

Is Stem Cell Therapy Safe for Type 1 Diabetes?

Stem cell therapy for Type 1 Diabetes is discussed only after an individual medical evaluation, and safety depends heavily on that case-by-case review rather than on the therapy in general. As with any medical intervention, mild and temporary reactions (such as soreness or fatigue at the injection or infusion site) are possible, and a full risk discussion happens as part of your evaluation. It is not offered to patients in an acute or unstable phase of Type 1 Diabetes, and it is never positioned as a substitute for guideline-based care from your treating specialist. For a fuller picture of how safety, accreditation, and quality standards are handled, see our Safety and Guarantees page.

12

Who Might Consider a Type 1 Diabetes Discussion — and Who Should Not

May be reasonable to discuss

  • A confirmed type 1 diabetes diagnosis, with the patient medically stable and not in an acute emergency
  • Prior imaging, neurology, and treatment records available for review
  • The injury is past its acute phase, with the patient in a stable, chronic-care stage
  • Realistic expectations that any benefit would be supportive and investigational, not a cure
  • Willingness to continue rehabilitation and follow-up care alongside this discussion

Generally not appropriate

  • Acute or unstable neurological emergencies requiring immediate critical care
  • Active untreated infection, uncontrolled bleeding disorder, or advanced organ failure
  • An active, untreated malignancy that has not been cleared by an oncologist
  • Pregnancy, or an expectation that the therapy will reverse or cure the underlying condition
  • Unwillingness to share prior medical records or to be evaluated before proceeding

This list is general and educational — it is not a substitute for an individual medical evaluation of your case.

13

What a Type 1 Diabetes Supportive-Care Discussion Involves

A supportive-care discussion for Type 1 Diabetes isn't a single conversation — it follows a defined sequence, so nothing is recommended before your specific case has been reviewed. In broad terms:

  1. Record review: Your existing diagnosis, imaging, lab work, and treatment history for Type 1 Diabetes are reviewed by the medical team first.
  2. Case-by-case medical evaluation: A physician assesses whether any further discussion is medically reasonable for your specific case — many enquiries end here with a clear "not appropriate" answer, which is a valid and expected outcome.
  3. Coordination with your specialist: Where a discussion proceeds, it is coordinated so it does not conflict with your ongoing care from your treating specialist.
  4. Transparent, written explanation: Any recommendation is explained in plain language, including its investigational status, realistic expectations, and that no outcome is guaranteed.
  5. Ongoing standard care continues: At every stage, your prescribed treatment for Type 1 Diabetes continues unless your own treating specialist changes it.

Nothing is scheduled or billed during this stage — it is a review and conversation, not a commitment.

14

Our Approach to Type 1 Diabetes Care

Stem Cell Care India has worked to build a reputation as one of the most trusted providers of stem cell treatment for diabetes in Delhi. Treatment is tailored to each patient’s specific goals, and based on experience supporting patients traveling from abroad, the team also assists with travel logistics, transportation, and accommodation to help make the overall experience as smooth as possible.

Commitments to patients include:

  • Assigning a capable, caring team dedicated to achieving the best possible treatment outcome.
  • Making arrangements to ensure comfort throughout the patient’s stay in India.
  • Providing complete transparency and honest guidance regarding treatment and any questions that arise.
  • Following strict safety standards to protect both patient health and overall care quality.
  • Remaining available and responsive throughout every stage of treatment.
15

Cost and How Stem Cell Therapy Compares for Type 1 Diabetes

While cost has historically limited access to stem cell therapy for some patients, the treatment offers meaningful potential benefits — including improved metabolism, increased energy, more regulated blood sugar, and better sleep. Stem Cell Care India works to keep pricing accessible without compromising quality or safety.

Affordable pricing doesn’t come at the expense of care quality — significant effort goes into ensuring treatments remain safe, effective, and convenient. Pricing is generally shaped by factors such as the type of treatment required, the severity of the patient’s diabetes, the number of stem cells recommended, and the patient’s age and weight.

Patients are encouraged to schedule a consultation with the treatment team to receive guidance tailored to their specific situation.

16

What Influences Type 1 Diabetes Outcomes

Stem cells are sometimes described as “master cells” that remain dormant in the body until signals from injury or chronic disease prompt them to respond, transforming into the specific cell types needed for repair. Researchers have developed methods to harvest and process these cells in a laboratory setting to maximize their therapeutic potential.

Stem Cell Care India has maintained consistent outcomes over time, with treatment plans customized to each patient’s needs to support the best possible chances of a positive result. Many patients have reported meaningful improvements in daily life following treatment.

17

Why Type 1 Diabetes Patients Consider Treatment in India

Diabetes was once thought to be manageable only through medication, diet, exercise, and routine glucose monitoring. Regenerative approaches using stem cells now offer patients an additional option that may reduce dependence on more invasive or costly interventions. Reported advantages include:

  • A streamlined 3-day process covering admission, stem cell implantation, supportive therapies, and discharge, allowing patients to return to daily life quickly.
  • The potential for injected stem cells to support the body’s own regenerative processes.
  • Use of Wharton’s jelly-derived mesenchymal stem cells, a naturally sourced and well-tolerated option.
  • A minimally invasive, patient-friendly implantation process.
  • Cost that, while a meaningful investment, is often lower than the cumulative cost of long-term conventional treatment.
18

Quality Control in Cell Processing for Type 1 Diabetes Therapy

Stem Cell Care India follows strict quality control measures throughout the treatment process, including:

  • Testing all stem cell sources to confirm they’re free of infectious microorganisms.
  • Periodic screening of cells for Gram-positive bacteria to rule out contamination.
  • Pre-treatment screening of media and instruments for Gram bacteria and Mycoplasma.
  • Final-wash testing of stem cells to check for aerobic or anaerobic microorganisms.
  • Endotoxin testing on every batch to confirm levels remain within safe limits.
  • Karyotyping to screen for mutated cells that may arise during isolation.

Once a batch passes these checks, it receives a Certificate of Analysis confirming its quality.

19

What Type 1 Diabetes Patients May Notice After Treatment

Diabetes management traditionally relies on insulin injections or insulin pumps, requiring frequent glucose monitoring and precise dosing. While effective at managing risk, researchers have explored whether stem cells might offer additional support — specifically, by helping form new pancreatic islets and supporting insulin-producing cell growth. While this doesn’t cure the underlying condition, some patients have gone extended periods without needing insulin injections following treatment. Stem Cell Care India, like a number of clinics worldwide, uses mesenchymal stem cells derived from Wharton’s jelly in the human umbilical cord for this purpose.

20

Type 1 Diabetes Patient Experiences

One patient shared that after hearing about stem cell therapy for diabetes, they weren’t sure what to expect — but described feeling noticeably better afterward, with reduced fatigue and better overall diabetes control, along with an improved quality of life.

Another patient described searching for options after their doctor suggested stem cell treatment for Type 1 diabetes, expressing initial hesitation about traveling abroad for care but ultimately finding the experience safe and the results effective.

A third patient described initial anxiety about the procedure and needles, but found the process far less uncomfortable than expected, with a caring provider who made them feel safe — reporting noticeable symptom improvement roughly three months after treatment.

21

Quality Certification for Type 1 Diabetes Therapy

A quality certificate is intended to document that the cell-processing steps used for a given batch were carried out under stated laboratory protocols and that the resulting cells met the facility's internal quality checks. Stem Cell Care India states that its cell-processing procedures are documented in this way, that patients are not charged extra for this documentation, and that equipment used is checked ahead of each procedure.

The clinic describes this certification as reflecting ethical practice, with patient safety, informed consent, and clear information treated as priorities, alongside ongoing internal checks on quality and procedure. This documentation reflects internal laboratory quality assurance rather than a government approval of the therapy itself for curing Type 1 Diabetes, and a supporting team of medical staff is described as being available throughout the process.

22

Type 1 Diabetes Follow-Up Care

Follow-up is a critical part of the treatment process, allowing doctors to monitor a patient’s progress and overall health. Patients are advised to attend follow-up visits as recommended by their doctor to help ensure the best possible outcome.

23

Supportive Therapies Sometimes Used Alongside Type 1 Diabetes Treatment

Stem cell therapy is generally discussed as one part of a broader recovery plan rather than a stand-alone treatment. Supportive therapies sometimes used alongside it for type 1 diabetes include:

  • Psychological support: To help address mood changes, anxiety, or emotional stress that can follow a type 1 diabetes.
  • Speech therapy: For patients experiencing difficulty speaking, swallowing, or understanding language.
  • Physiotherapy: To help rebuild movement, balance, and muscle strength.
  • Hyperbaric oxygen therapy: Delivering oxygen at increased pressure, which is being explored as a supportive measure for tissue recovery.
  • Acupuncture: Used by some patients as a complementary approach alongside conventional care.
  • Rehabilitation therapy: Structured practice of daily tasks to support functional recovery.
  • Occupational therapy: Support for relearning tasks such as dressing, eating, and writing.
  • Nutrition therapy: Dietary guidance intended to support general recovery.
  • Nerve Growth Factor (NGF) treatment: Supports the survival and growth of nerve cells; when discussed alongside stem cell therapy, it is explored for its potential to support nerve repair and overall brain recovery.

Any combination of these should be planned together with the treating medical team rather than pursued independently.

24

Why Some International Type 1 Diabetes Patients Consider India

Type 1 diabetes can seriously affect quality of life — causing fatigue, weight loss, frequent urination, and intense thirst, and over time raising the risk of damage to the heart, kidneys, eyes, and nerves. This happens because the immune system attacks the pancreas’s insulin-producing cells, and without this hormone, blood sugar cannot be properly regulated. The exact cause remains unclear, though both genetic and environmental factors are thought to play a role.

Doctors turn to stem cell therapy for its regenerative and anti-inflammatory potential, aiming to support insulin production and help reduce a patient’s reliance on daily injections.

International Patients Taking Advantage of India’s Medical Facilities

India has become a popular destination for international patients — from the UK, Europe, USA, Philippines, Singapore, Bhutan, Nepal, Greece, and elsewhere — seeking Type 1 diabetes stem cell treatment, supported by several key facilities:

1. Medical Facilities

  • Advanced Stem Cell Therapy: Leading hospitals offer regenerative treatment aimed at improving insulin production.
  • Experienced Specialists: Highly trained doctors and researchers specialize in stem cell therapy and diabetes care.
  • State-of-the-Art Laboratories: Advanced facilities support high-quality stem cell processing.
  • Comprehensive Treatment Plans: Customized care includes pre- and post-therapy support.

2. Patient Support Services

  • Dedicated International Patient Departments: Teams assist with appointments, documentation, and follow-up.
  • Language Assistance: Translators help patients communicate with medical staff.
  • Medical Visa Assistance: Support with visa procedures for international patients.

3. Comfort and Accommodation

  • On-Campus Stay Facilities: In-house guest houses or nearby hotel partnerships.
  • Dietary Services: Diabetic-friendly meal planning available.
  • 24/7 Emergency Care: Round-the-clock support for international patients.

4. Travel and Post-Treatment Care

  • Airport Transfers: Pick-up and drop-off arranged for patients and families.
  • Follow-Up Care: Online consultations available for post-treatment monitoring.

These services have made India a preferred destination for patients seeking effective, affordable stem cell treatment for Type 1 diabetes, supported by skilled specialists and reasonable costs.

25

Selected Type 1 Diabetes Research & Publications

  • Autologous HSCT Preserves Beta-Cell Function in New-Onset T1DM (BRAMBLE Trial) — Couri CE et al., JAMA
  • Stem Cell-Derived Beta Cells for T1DM (VX-880 Clinical Trial) — Shapiro AMJ et al., New England Journal of Medicine
  • Umbilical Cord MSC for T1DM: Phase I/II C-Peptide Outcomes — Hu J et al., Endocrine Journal
  • Wharton’s Jelly MSC for Recent-Onset T1DM: Dose-Escalation Trial — Carlsson PO et al., Diabetes
  • Exosome-Based Immunotherapy for T1DM: Autoimmune Suppression — Onate B et al., Diabetes
  • MSC Transplantation for T1DM: Treg Expansion and Beta-Cell Protection — Voltarelli JC et al., Diabetes Care
  • Human Islet Transplantation for T1DM: Edmonton Protocol Long-Term — Shapiro AMJ et al., New England Journal of Medicine
  • Pancreatic Progenitor Cells from ESC for T1DM: Phase I Safety — Kroon E et al., Nature Biotechnology
  • Allogeneic MSC Infusion Prolongs C-Peptide in New-Onset T1DM — Fiorina P et al., Diabetes Care
  • BM-MSC Immunomodulation Arrests Autoimmune Destruction in T1DM — Zhao Y et al., PLOS ONE
26

Conclusion: Stem Cell Therapy for Type 1 Diabetes

Topic 26 of 26

Type 1 diabetes requires lifelong care and attention, as the immune system’s ongoing attack on insulin-producing cells leaves the body unable to balance blood sugar on its own. This makes daily insulin support essential, and many patients face daily challenges from both high and low blood sugar episodes.

Stem cell therapy cannot cure Type 1 diabetes, but it may offer supportive benefits — helping reduce inflammation, supporting damaged tissue, and promoting healthier cell activity. Some patients report better energy levels and improved healing over time, alongside gradually improving stability.

The therapy may also help slow immune overreaction and offer some protection to remaining beta cells, potentially improving day-to-day wellness and helping the body manage stress more effectively. Insulin remains necessary for most patients, but quality of life may improve steadily with consistent monitoring and care.

Understanding the condition, acting early, and maintaining consistent treatment all support better long-term outcomes and a more manageable day-to-day life.

Treatment Disclaimer: We provide consultation, case evaluation, and patient support services in the field of regenerative medicine. As per current medical guidelines in India, stem cell-based interventions (other than approved indications) are considered investigational and are available only within regulated clinical research settings. For patients exploring broader options, we also assist in facilitating access to treatment pathways, including internationally accredited centers where different regulatory frameworks may apply.

Still deciding? ★★★★★ 4.9/5 from 193+ verified patients A free medical review shows whether it's worth pursuing for your specific case — no obligation.

Not sure if this applies to your case?

Share your diagnosis and reports, and our medical team will get back to you with a free, doctor-reviewed opinion on Type 1 Diabetes — no obligation.

  • Reviewed by our in-house medical team
  • Doctor-reviewed reply within 24–48 hours
  • No cost and no obligation to proceed
  • Your information is kept confidential

Get Your Free Evaluation

1. Your details 2. Your case
Common Questions

Frequently Asked Questions

Type 1 diabetes occurs when the pancreas produces little to no insulin, the hormone needed for glucose to enter cells for energy. Without it, glucose builds up in the bloodstream. It affects roughly 1 in 400 young people under 20, and while there’s currently no cure, insulin therapy remains the primary treatment.

The condition arises when the immune system mistakenly attacks the pancreas’s insulin-producing beta cells, eventually destroying around 90% of them and severely limiting the body’s ability to produce insulin. Symptoms include:

Extreme hunger alongside weight loss

Increased appetite and frequent urination

Persistent exhaustion

Emotional outbursts

Blurred vision (uncommon, but possible with very high blood sugar)

More severe symptoms if left untreated, including nausea, vomiting, stomach pain, rapid breathing, drowsiness, and in serious cases, loss of consciousness

The therapy aims to help repair or replace weakened or damaged insulin-producing beta cells, supporting more natural insulin activity and helping the body manage glucose more effectively. Over time, this may help reduce daily insulin requirements and improve long-term sugar control, all under close monitoring.

Stem cells may support new beta-cell growth while helping calm harmful immune activity, protecting the pancreas from further damage. This can translate into steadier insulin release, more stable daily glucose levels, and improved energy over time.

Results vary significantly between patients. While the therapy may reduce insulin requirements for some, complete insulin independence isn’t guaranteed and depends on how well beta-cell function recovers. The broader goal is better long-term glucose stability rather than full insulin replacement.

By calming excess immune activity and inflammation, stem cells may help protect remaining beta cells and support gradual healing, allowing the pancreas to function more smoothly and slowing further damage.

Stem cells may help regulate immune responses and reduce the intensity of autoimmune activity, offering better protection to beta cells and supporting more stable long-term glucose control.

Some children may be eligible following a full medical evaluation, since safety remains the top priority. While younger patients sometimes heal faster, immune activity can also be more pronounced, so careful monitoring and parental involvement are essential.

The therapy is considered safe when performed under medical supervision using carefully screened cells. Side effects, when they occur, are generally mild — such as temporary fatigue or discomfort — and regular follow-up helps ensure a safe recovery.

Patients with early-stage Type 1 diabetes, ongoing inflammation, or high insulin needs may be good candidates, as may adults and teens without major complications. Final eligibility depends on a full medical evaluation.

Diagnosis relies on recognizing classic symptoms alongside elevated blood sugar and ketones in the urine. A 3-month average blood sugar test (HbA1c) showing 6.5% or higher confirms diabetes.

Results tend to build gradually over several months, with some early changes appearing within weeks. Beta-cell recovery and reduced inflammation both take time, and doctors monitor progress closely throughout.

Benefits may last several years depending on cell survival and lifestyle factors. A healthy diet, regular checkups, and reduced inflammation can all help sustain results, though outcomes vary from patient to patient.

Not fully sure which diagnosis fits? Send both reports and our medical team will confirm which condition applies — often within 24–48 hours.

If a caregiver or patient you know is dealing with a different diagnosis, this covers the same treatment approach for another common condition:

All Treatments

Explore Other Categories

Editorial & Medical Standards

Medically reviewed by the Stem Cell Care India clinical team. Last reviewed 2 September 2026. Written by Nishat Arfin · Scientific review by Tabish Iqbal · Medically approved by the Stem Cell Care India Medical Team.


Talk to a case coordinator about your specific condition and treatment options.

24–48hFrom sending your reports to a doctor-reviewed answer
10,000+Patients treated across 65+ countries
4.9 / 5From 193+ verified Google reviews

Talk to a case coordinator about your specific condition and treatment options.

24–48hFrom sending your reports to a doctor-reviewed answer
10,000+Patients treated across 65+ countries
4.9 / 5From 196+ verified Google reviews

Patient stories — Diabetes

Stem Cell Therapy for Type 1 Diabetes – UAE Patient

Sami Mohammad Alfaraj from Kuwait came India for Type 2 Diabetes

Patient With Type 2 Diabetes Came From Nepal

Patient With Type 1 Diabetes From India Share His Experience

See all patient videos →